Glucose Health, Inc. (GLUC) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
609 SW 8TH STREET BENTONVILLE, AR 72712 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 17 | 18 | 9 | 21 | 24 | 28 | 2 | ||
| Cash and cash equivalents | 17 | 18 | 9 | 21 | 24 | 28 | 2 | ||
| Receivables | 9 | 9 | 10 | 12 | 12 | 168 | 3 | ||
| Inventory, net of allowances, customer advances and progress billings | 6 | 8 | 8 | ||||||
| Inventory | 6 | 8 | 8 | ||||||
| Prepaid expense | 0 | 1 | 2 | 2 | 38 | ||||
| Other undisclosed current assets | 0 | 0 | 0 | ||||||
| Total current assets: | 26 | 27 | 19 | 33 | 44 | 207 | 51 | ||
| Noncurrent Assets | |||||||||
| Intangible assets, net (including goodwill) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Intangible assets, net (excluding goodwill) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Deferred costs | (0) | ||||||||
| Other undisclosed noncurrent assets | 0 | ||||||||
| Total noncurrent assets: | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| TOTAL ASSETS: | 26 | 27 | 19 | 33 | 44 | 207 | 52 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 78 | 98 | 152 | 138 | 124 | 169 | 95 | ||
| Interest and dividends payable | 33 | 27 | |||||||
| Accrued liabilities | 41 | 38 | 39 | 5 | |||||
| Other undisclosed accounts payable and accrued liabilities | 37 | 60 | 113 | 133 | 91 | 143 | 95 | ||
| Debt | 10 | 15 | 5 | 39 | 5 | 36 | 6 | ||
| Due to related parties | 35 | 35 | 35 | 112 | 35 | ||||
| Other undisclosed current liabilities | 329 | 328 | 350 | 240 | 253 | 218 | 354 | ||
| Total current liabilities: | 453 | 477 | 542 | 529 | 418 | 424 | 455 | ||
| Noncurrent Liabilities | |||||||||
| Total liabilities: | 453 | 477 | 542 | 529 | 418 | 424 | 455 | ||
| Equity | |||||||||
| Equity, attributable to parent, including: | (426) | (449) | (524) | (495) | (374) | (217) | (403) | ||
| Preferred stock | 113 | 113 | 113 | 113 | 113 | 113 | 113 | ||
| Common stock | 5 | 4 | 3 | 3 | 3 | 3 | 3 | ||
| Common stock, value, subscriptions | 23 | 23 | 23 | 23 | 23 | 23 | 23 | ||
| Additional paid in capital | 5,717 | 5,713 | 5,689 | 120 | 5,686 | 5,682 | 5,400 | ||
| Accumulated other comprehensive loss | (75) | (75) | (75) | (75) | (75) | (75) | (75) | ||
| Accumulated deficit | (6,209) | (6,227) | (6,277) | (6,248) | (6,124) | (5,963) | (5,866) | ||
| Other undisclosed equity, attributable to parent | 5,568 | ||||||||
| Total equity: | (426) | (449) | (524) | (495) | (374) | (217) | (403) | ||
| TOTAL LIABILITIES AND EQUITY: | 26 | 27 | 19 | 33 | 44 | 207 | 52 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 24 | 34 | 15 | 15 | 2 | 296 | 0 | |
| Cost of revenue | (1) | (0) | (15) | (15) | (5) | (274) | (0) | |
| Cost of goods and services sold | (5) | (274) | (0) | |||||
| Gross profit: | 23 | 34 | 0 | 0 | (3) | 21 | 0 | |
| Operating expenses | (18) | (18) | (29) | (25) | (53) | (15) | (12) | |
| Operating income (loss): | 5 | 16 | (28) | (25) | (56) | 6 | (12) | |
| Nonoperating income (expense) | 14 | 33 | (1) | (99) | (105) | (93) | (17) | |
| Interest and debt expense | (6) | (5) | (1) | (99) | (105) | (93) | (17) | |
| Income (loss) from continuing operations before equity method investments, income taxes: | 13 | 44 | (30) | (223) | (266) | (181) | (46) | |
| Other undisclosed income from continuing operations before income taxes | 6 | 5 | 1 | 99 | 105 | 93 | 17 | |
| Income (loss) from continuing operations: | 19 | 49 | (29) | (124) | (161) | (87) | (29) | |
| Income (loss) before gain (loss) on sale of properties: | 19 | 49 | (29) | (124) | (161) | (87) | (29) | |
| Net income (loss) available to common stockholders, diluted: | 19 | 49 | (29) | (124) | (161) | (87) | (29) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 19 | 49 | (29) | (124) | (161) | (87) | (29) | |
| Comprehensive income (loss), net of tax, attributable to parent: | 19 | 49 | (29) | (124) | (161) | (87) | (29) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.